ARK Investment Management - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$62,725,728
-10.6%
11,509,308
+10.1%
0.48%
+3.4%
Q2 2023$70,144,675
-13.7%
10,453,752
+13.6%
0.46%
-17.0%
Q1 2023$81,281,254
+15.6%
9,205,125
+0.0%
0.56%
-8.2%
Q4 2022$70,297,512
+5.7%
9,201,245
-1.4%
0.61%
+31.5%
Q3 2022$66,477,000
-3.1%
9,336,619
+6.4%
0.46%
+14.0%
Q2 2022$68,605,000
-35.9%
8,773,018
+13.8%
0.41%
-9.2%
Q1 2022$107,010,000
-33.1%
7,709,666
+35.3%
0.45%
-7.5%
Q4 2021$159,882,000
-3.1%
5,697,868
+17.3%
0.48%
+22.0%
Q3 2021$165,070,000
-7.5%
4,856,421
+11.2%
0.40%
+19.3%
Q2 2021$178,435,000
+27.6%
4,366,977
+25.7%
0.33%
+19.4%
Q1 2021$139,860,000
+53.0%
3,473,910
+124.7%
0.28%
+14.4%
Q4 2020$91,397,000
+112.4%
1,545,703
+74.7%
0.24%
-4.7%
Q3 2020$43,024,000
+187.7%
884,722
+186.2%
0.26%
+58.4%
Q2 2020$14,956,000309,1380.16%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders